市場調査レポート
商品コード
1318852
全身性エリテマトーデス市場:薬剤タイプ、ドラッグデリバリー方式別-2023~2030年の世界予測Systemic Lupus Erythematosus Market by Drug Type, Mode of Delivery - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
全身性エリテマトーデス市場:薬剤タイプ、ドラッグデリバリー方式別-2023~2030年の世界予測 |
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
|
全身性エリテマトーデスの世界市場は、2023年にCAGR 10.47%で20億4,387万米ドルが予測され、2030年には41億2,270万米ドルに達するという驚異的な成長を遂げると予測されています。
FPNVポジショニングマトリックスは世界の全身性エリテマトーデス市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。
市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。
本レポートは、以下のポイントに関する洞察を提供します:
1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。
2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。
3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。
4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。
5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。
6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。
本レポートは、以下のような質問にお答えします:
1.全身性エリテマトーデスの世界市場規模および予測は?
2.予測期間中、世界の全身性エリテマトーデス市場を形成するCOVID-19の阻害要因と影響は?
3.全身性エリテマトーデスの世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は?
4.全身性エリテマトーデスの世界市場における競争戦略は?
5.全身性エリテマトーデスの世界市場における技術動向と規制の枠組みは?
6.全身性エリテマトーデスの世界市場における主要ベンダーの市場シェアは?
7.全身性エリテマトーデスの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?
The Global Systemic Lupus Erythematosus Market is forecasted to grow significantly, with a projected USD 2,043.87 million in 2023 at a CAGR of 10.47% and expected to reach a staggering USD 4,122.70 million by 2030.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Systemic Lupus Erythematosus Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Based on Drug Type, market is studied across B-Cell Modulators, Antimalarial Drugs, Biologics, Cytotoxic & Immunosuppressive Drugs, Immunosuppressive & Cytotoxic Drugs & T-Cell Modulators, Non-Steroidal Anti-Inflammatory Drugs, and Pro-Inflammatory & Cytokine Inhibitors. The Antimalarial Drugs is further studied across Chloroquine and Hydrochloroquine. The Biologics is further studied across Approved Biologics for Treating SLE and Biologics Used Off-Label. The Approved Biologics for Treating SLE is further studied across B-Cell Targeted Therapy and Blys-Blockers (Belimumab). The Cytotoxic & Immunosuppressive Drugs is further studied across Cyclophosphamide, Cyclosporine, Methotrexate, and Mycophenolate Mofetil or Tacrolimus. The Antimalarial Drugs is projected to witness significant market share during forecast period.
Based on Mode of Delivery, market is studied across Intravenous, Oral, Subcutaneous, and Topical. The Subcutaneous is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is essential for assessing the Global Systemic Lupus Erythematosus Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Systemic Lupus Erythematosus Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Systemic Lupus Erythematosus Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Systemic Lupus Erythematosus Market?
4. What is the competitive strategic window for opportunities in the Global Systemic Lupus Erythematosus Market?
5. What are the technology trends and regulatory frameworks in the Global Systemic Lupus Erythematosus Market?
6. What is the market share of the leading vendors in the Global Systemic Lupus Erythematosus Market?
7. What modes and strategic moves are considered suitable for entering the Global Systemic Lupus Erythematosus Market?